Drug Dosing in the Critically Ill Obese Patient

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Unfortunately, research related to drug dosing in overweight and obese patients has not kept pace with studies concerning the epidemiology and complications of obesity. The pivotal trials leading to drug approval typically include relatively few patients with extremes of weight relative to height. They usually focus on patients in non-ICU settings, and in some cases specifically exclude patients beyond a predefined weight. Furthermore, when the results of clinical trials are reported, patient weights are usually expressed in terms of summary statistics. Although patient weight is often the focus of discussions of drugs administered using weight-based dosing regimens, other factors such as height and body composition must be taken into account. As much as possible and practical, the way in which weight is estimated, measured, recorded, and utilized for drug dosing should be standardized to reduce variability that might lead to dosing errors.

Original languageEnglish (US)
Title of host publicationCritical Care Management of the Obese Patient
PublisherWiley-Blackwell
Pages195-207
Number of pages13
ISBN (Print)9780470655900
DOIs
StatePublished - Apr 19 2012

Keywords

  • Adverse drug events
  • Critical care
  • Dosing
  • Drugs
  • Obesity
  • Pharmacokinetics
  • Size descriptors
  • Weight

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Drug Dosing in the Critically Ill Obese Patient'. Together they form a unique fingerprint.

  • Cite this

    Erstad, B. L. (2012). Drug Dosing in the Critically Ill Obese Patient. In Critical Care Management of the Obese Patient (pp. 195-207). Wiley-Blackwell. https://doi.org/10.1002/9781119962083.ch22